These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18195067)

  • 1. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.
    Cuenca-Estrella M; Alastruey-Izquierdo A; Alcazar-Fuoli L; Bernal-Martinez L; Gomez-Lopez A; Buitrago MJ; Mellado E; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1136-9. PubMed ID: 18195067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.
    Yustes C; Guarro J
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3498-500. PubMed ID: 16048969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of conventional antifungal agents against Scedosporium apiospermum isolates recovered from clinical and environmental samples in Nigeria.
    Nweze EI; Okafor JI
    Acta Microbiol Immunol Hung; 2010 Sep; 57(3):209-14. PubMed ID: 20870592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
    Gosbell IB; Toumasatos V; Yong J; Kuo RS; Ellis DH; Perrie RC
    Mycoses; 2003 Jun; 46(5-6):233-6. PubMed ID: 12801370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.
    Rodríguez MM; Calvo E; Serena C; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2009 May; 53(5):2153-5. PubMed ID: 19223617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
    Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ
    J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.
    Lackner M; Fernández-Silva F; Guarro J; Lass-Flörl C
    J Antimicrob Chemother; 2014 Nov; 69(11):3027-32. PubMed ID: 24986494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.
    Kirchhoff L; Dittmer S; Buer J; Rath PM; Steinmann J
    Int J Antimicrob Agents; 2020 Sep; 56(3):106105. PubMed ID: 32721601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.
    Heath CH; Slavin MA; Sorrell TC; Handke R; Harun A; Phillips M; Nguyen Q; Delhaes L; Ellis D; Meyer W; Chen SC;
    Clin Microbiol Infect; 2009 Jul; 15(7):689-93. PubMed ID: 19549223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Scedosporium isolates to N-acetyl-L-cysteine alone and in combination with conventional antifungal agents.
    Homa M; Galgóczy L; Tóth E; Virágh M; Chandrasekaran M; Vágvölgyi C; Papp T
    Med Mycol; 2016 Oct; 54(7):776-9. PubMed ID: 27143635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.
    Afeltra J; Dannaoui E; Meis JF; Rodriguez-Tudela JL; Verweij PE
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3323-6. PubMed ID: 12234872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
    Howden BP; Slavin MA; Schwarer AP; Mijch AM
    Eur J Clin Microbiol Infect Dis; 2003 Feb; 22(2):111-3. PubMed ID: 12627286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi.
    Wiederhold NP; Lewis RE
    Med Mycol; 2009 Jun; 47(4):422-32. PubMed ID: 19058049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal activity of antipsychotic drugs and their combinations with conventional antifungals against Scedosporium and Pseudallescheria isolates.
    Homa M; Galgóczy L; Tóth E; Tóth L; Papp T; Chandrasekaran M; Kadaikunnan S; Alharbi NS; Vágvölgyi C
    Med Mycol; 2015 Nov; 53(8):890-5. PubMed ID: 26316212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphadenitis caused by Scedosporium apiospermum in an immunocompetent patient.
    Kiraz N; Gülbas Z; Akgün Y; Uzun O
    Clin Infect Dis; 2001 Feb; 32(3):E59-61. PubMed ID: 11170973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections caused by Scedosporium spp.
    Cortez KJ; Roilides E; Quiroz-Telles F; Meletiadis J; Antachopoulos C; Knudsen T; Buchanan W; Milanovich J; Sutton DA; Fothergill A; Rinaldi MG; Shea YR; Zaoutis T; Kottilil S; Walsh TJ
    Clin Microbiol Rev; 2008 Jan; 21(1):157-97. PubMed ID: 18202441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scedosporium apiospermum keratitis treated with itraconazole.
    Saracli MA; Erdem U; Gonlum A; Yildiran ST
    Med Mycol; 2003 Apr; 41(2):111-4. PubMed ID: 12964842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of four novel triazoles against Scedosporium spp.
    Carrillo AJ; Guarro J
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2151-3. PubMed ID: 11408242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
    Wiederhold NP; Law D; Birch M
    J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.